Kennedy-Wilson Acquired at $10.90 Cash per Share
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 17 2026
0mins
Should l Buy KW?
Kennedy-Wilson and Fairfax Financial jointly announced that the company has entered into a definitive agreement providing for Kennedy Wilson to be acquired, in an all cash-transaction, by an entity affiliated with a consortium led by William McMorrow, Chairman and CEO of the company, and certain other senior executives of the company, together with Fairfax. Under the terms of the Merger Agreement, the Consortium will acquire all outstanding common shares of Kennedy Wilson other than certain shares owned by the members of the Consortium and their respective affiliates for $10.90 per share in cash. The per share purchase price represents a 46% premium to Kennedy Wilson's unaffected share price as of November 4, 2025, the last trading day prior to a publicly disclosed proposal received by the company after market close on November 4, 2025 from the Consortium to acquire Kennedy Wilson. Each member of the Consortium has entered into a voting and support agreement whereby each has agreed to vote in favor of the Transaction in accordance with the terms and conditions thereof. Concurrent with entering into the Merger Agreement, Fairfax has entered into a commitment letter pursuant to which Fairfax has committed to provide the Consortium with funding up to an aggregate amount of $1.65B, which is the amount necessary to fund the cash purchase price in respect of the Transaction, the redemption of those preferred shares of the Company not owned by the Consortium, and certain other amounts required to be paid under the terms of the Merger Agreement. The Transaction is not subject to a financing condition. Following consummation of the Transaction, the KW Management Group, led by William McMorrow, will have effective and operational control of and will continue to lead and have ultimate responsibility for the Company and its subsidiaries. Fairfax is expected to have a majority of the economic interest in the Company immediately following the closing of the Transaction. The Transaction is expected to close in the second quarter of 2026.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KW?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KW
Wall Street analysts forecast KW stock price to rise
1 Analyst Rating
0 Buy
0 Hold
1 Sell
Moderate Sell
Current: 10.950
Low
11.00
Averages
11.00
High
11.00
Current: 10.950
Low
11.00
Averages
11.00
High
11.00
About KW
Kennedy-Wilson Holdings, Inc. is a global real estate investment company. It owns, operates and builds real estate within its core real estate portfolio and through its investment management platform. It focuses on investing in the rental housing sector (both market rate and affordable units) and industrial properties; and originating, managing and servicing real estate loans (senior construction loans secured by multifamily and student housing properties that are being developed by institutional sponsors throughout the United States). Its segments include Consolidated Portfolio and Co-Investment Portfolio. Its Consolidated Portfolio consists of the investments in real estate and real estate-related assets that it has made and consolidated on its balance sheet, primarily multifamily communities. Under the Co-Investment Portfolio, it invests capital on behalf of its partners in real estate and real estate-related assets, primarily construction loans, through its Co-Investment Portfolio.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Kennedy-Wilson Q1 Earnings Beat Expectations
- Earnings Beat: Kennedy-Wilson reported a Q1 GAAP EPS of $0.10, exceeding expectations by $0.25, indicating resilience in profitability despite challenging market conditions.
- Revenue Decline: The company recorded revenue of $117.2 million, down 8.7% year-over-year, reflecting challenges in revenue growth amid increased competition and market volatility, which may impact future investment decisions.
- Debt Exchange Termination: Kennedy-Wilson announced the termination of its senior notes exchange offer, a move that could affect the company's capital structure and financing strategy, necessitating close monitoring of subsequent financial adjustments.
- Increased Market Attention: Following the earnings release, market interest in Kennedy-Wilson has heightened, particularly in the context of deals involving Visa, Hims & Hers Health, and Salesforce, potentially opening new collaboration opportunities for the company.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Merger Investigation: Halper Sadeh LLC is investigating the merger between McCormick & Company and Unilever's Foods business, where McCormick shareholders will own 35% of the combined company upon closing, potentially impacting shareholder rights and market competition.
- Shareholder Rights Protection: Leggett & Platt is selling to Somnigroup International Inc. for 0.1455 shares of Somnigroup common stock per share of Leggett & Platt, resulting in shareholders owning approximately 9% of the combined company, prompting Halper Sadeh LLC to remind shareholders of their legal rights.
- Acquisition Price Dispute: Organon & Co. is being sold to Sun Pharmaceutical Industries for $14.00 per share, with Halper Sadeh LLC potentially seeking to increase the acquisition price to ensure shareholders receive fair compensation.
- Internal Transaction Review: Kennedy-Wilson Holdings is being sold for $10.90 per share in cash to a consortium led by executives, with Halper Sadeh LLC possibly requesting additional information and disclosures to protect shareholder interests.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Background: Halper Sadeh LLC is investigating Kennedy-Wilson Holdings, Inc. (NYSE:KW) regarding its sale to a consortium led by CEO William McMorrow for $10.90 per share in cash, raising concerns about potential breaches of fiduciary duties to shareholders.
- Transaction Terms: Thermon Group Holdings, Inc. (NYSE:THR) is set to sell to CECO Environmental Corp., offering shareholders options including $10.00 in cash plus 0.6840 shares of CECO stock, $63.89 per share, or 0.8110 shares of CECO stock, which may influence shareholder decisions significantly.
- Merger Dynamics: Northfield Bancorp, Inc. (NASDAQ:NFBK) is merging with Columbia Financial, Inc., and Halper Sadeh LLC is urging shareholders to understand their legal rights and options to protect their interests during this process.
- Legal Support: Halper Sadeh LLC represents investors globally, aiming to seek increased consideration and additional disclosures, thereby providing legal support and relief for those affected by securities fraud and corporate misconduct.
See More
Julie & Holleman Investigates Kennedy-Wilson Buyout Deal
- Investigation Launched: Julie & Holleman LLP is investigating the $10.90 per share buyout of Kennedy-Wilson Holdings by insiders and Fairfax Financial, totaling approximately $1.9 billion, raising concerns about the fairness of the deal.
- Asset Management Scale: Kennedy-Wilson is a leading real estate investment firm with $31 billion in assets under management, primarily in high-growth markets across the U.S., UK, and Ireland, underscoring its significant industry presence.
- Shareholder Rights Issues: The deal will cash out public shareholders, eliminating their ownership, which raises concerns from Julie & Holleman about potential conflicts of interest as insiders remain with the company, potentially affecting the deal's fairness.
- Litigation Potential: Julie & Holleman’s attorneys have secured hundreds of millions in past cases for shareholders, demonstrating their strong capability in shareholder rights protection, which may challenge the legality of this transaction.
See More
Kennedy-Wilson Terminates Bond Exchange Offers
- Bond Exchange Termination: Kennedy-Wilson's subsidiary has immediately terminated its previously announced bond exchange offers, which involved swapping existing 4.750% and 5.000% senior notes for new 6.125% and 6.375% notes, potentially impacting the company's financing flexibility.
- Merger Progress: The company's planned merger, expected to close in Q2 2026 and led by Chairman & CEO William McMorrow with support from Fairfax Financial Holdings, is set to provide strategic backing for future growth opportunities.
- Market Reaction: Following the announcement of a $10.90 per share all-cash take-private deal, Kennedy-Wilson's stock jumped, reflecting market confidence in the company's future, although the termination of the bond exchange may raise investor concerns.
- Financial Impact Assessment: The decision to terminate the bond exchange and consent solicitation could have a short-term negative impact on the company's capital structure, particularly in the current interest rate environment, potentially limiting its future financing capabilities and flexibility.
See More
Kennedy-Wilson Terminates Bond Exchange Offers and Consent Solicitations
- Termination of Exchange Offers: Kennedy-Wilson has announced the immediate termination of its exchange offers for the 4.750% and 5.000% Senior Notes due 2029, 2030, and 2031, meaning holders cannot exchange existing notes for the newly issued 6.125% and 6.375% notes, which impacts the company's financing flexibility.
- Proposed Amendments Rejected: The termination of the consent solicitations means that the proposed amendments to the indentures governing the existing notes will not be adopted, potentially limiting the company's debt management strategies and future financing capabilities.
- Merger Unaffected: Despite the termination of the exchange offers and consent solicitations, the proposed acquisition by a consortium led by William McMorrow is expected to close in Q2 2026, indicating the independence of the merger from these financial maneuvers and the continuity of the company's strategic direction.
- Role of Information Agent: D.F. King & Co., Inc. served as the exchange and information agent for the terminated offers, providing necessary support to ensure investors receive timely information, thereby maintaining communication channels between the company and its investors.
See More
Kennedy-Wilson Q1 Earnings Beat Expectations
- Earnings Beat: Kennedy-Wilson reported a Q1 GAAP EPS of $0.10, exceeding expectations by $0.25, indicating resilience in profitability despite challenging market conditions.
- Revenue Decline: The company recorded revenue of $117.2 million, down 8.7% year-over-year, reflecting challenges in revenue growth amid increased competition and market volatility, which may impact future investment decisions.
- Debt Exchange Termination: Kennedy-Wilson announced the termination of its senior notes exchange offer, a move that could affect the company's capital structure and financing strategy, necessitating close monitoring of subsequent financial adjustments.
- Increased Market Attention: Following the earnings release, market interest in Kennedy-Wilson has heightened, particularly in the context of deals involving Visa, Hims & Hers Health, and Salesforce, potentially opening new collaboration opportunities for the company.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Merger Investigation: Halper Sadeh LLC is investigating the merger between McCormick & Company and Unilever's Foods business, where McCormick shareholders will own 35% of the combined company upon closing, potentially impacting shareholder rights and market competition.
- Shareholder Rights Protection: Leggett & Platt is selling to Somnigroup International Inc. for 0.1455 shares of Somnigroup common stock per share of Leggett & Platt, resulting in shareholders owning approximately 9% of the combined company, prompting Halper Sadeh LLC to remind shareholders of their legal rights.
- Acquisition Price Dispute: Organon & Co. is being sold to Sun Pharmaceutical Industries for $14.00 per share, with Halper Sadeh LLC potentially seeking to increase the acquisition price to ensure shareholders receive fair compensation.
- Internal Transaction Review: Kennedy-Wilson Holdings is being sold for $10.90 per share in cash to a consortium led by executives, with Halper Sadeh LLC possibly requesting additional information and disclosures to protect shareholder interests.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Background: Halper Sadeh LLC is investigating Kennedy-Wilson Holdings, Inc. (NYSE:KW) regarding its sale to a consortium led by CEO William McMorrow for $10.90 per share in cash, raising concerns about potential breaches of fiduciary duties to shareholders.
- Transaction Terms: Thermon Group Holdings, Inc. (NYSE:THR) is set to sell to CECO Environmental Corp., offering shareholders options including $10.00 in cash plus 0.6840 shares of CECO stock, $63.89 per share, or 0.8110 shares of CECO stock, which may influence shareholder decisions significantly.
- Merger Dynamics: Northfield Bancorp, Inc. (NASDAQ:NFBK) is merging with Columbia Financial, Inc., and Halper Sadeh LLC is urging shareholders to understand their legal rights and options to protect their interests during this process.
- Legal Support: Halper Sadeh LLC represents investors globally, aiming to seek increased consideration and additional disclosures, thereby providing legal support and relief for those affected by securities fraud and corporate misconduct.
See More
Julie & Holleman Investigates Kennedy-Wilson Buyout Deal
- Investigation Launched: Julie & Holleman LLP is investigating the $10.90 per share buyout of Kennedy-Wilson Holdings by insiders and Fairfax Financial, totaling approximately $1.9 billion, raising concerns about the fairness of the deal.
- Asset Management Scale: Kennedy-Wilson is a leading real estate investment firm with $31 billion in assets under management, primarily in high-growth markets across the U.S., UK, and Ireland, underscoring its significant industry presence.
- Shareholder Rights Issues: The deal will cash out public shareholders, eliminating their ownership, which raises concerns from Julie & Holleman about potential conflicts of interest as insiders remain with the company, potentially affecting the deal's fairness.
- Litigation Potential: Julie & Holleman’s attorneys have secured hundreds of millions in past cases for shareholders, demonstrating their strong capability in shareholder rights protection, which may challenge the legality of this transaction.
See More
Kennedy-Wilson Terminates Bond Exchange Offers
- Bond Exchange Termination: Kennedy-Wilson's subsidiary has immediately terminated its previously announced bond exchange offers, which involved swapping existing 4.750% and 5.000% senior notes for new 6.125% and 6.375% notes, potentially impacting the company's financing flexibility.
- Merger Progress: The company's planned merger, expected to close in Q2 2026 and led by Chairman & CEO William McMorrow with support from Fairfax Financial Holdings, is set to provide strategic backing for future growth opportunities.
- Market Reaction: Following the announcement of a $10.90 per share all-cash take-private deal, Kennedy-Wilson's stock jumped, reflecting market confidence in the company's future, although the termination of the bond exchange may raise investor concerns.
- Financial Impact Assessment: The decision to terminate the bond exchange and consent solicitation could have a short-term negative impact on the company's capital structure, particularly in the current interest rate environment, potentially limiting its future financing capabilities and flexibility.
See More
Kennedy-Wilson Terminates Bond Exchange Offers and Consent Solicitations
- Termination of Exchange Offers: Kennedy-Wilson has announced the immediate termination of its exchange offers for the 4.750% and 5.000% Senior Notes due 2029, 2030, and 2031, meaning holders cannot exchange existing notes for the newly issued 6.125% and 6.375% notes, which impacts the company's financing flexibility.
- Proposed Amendments Rejected: The termination of the consent solicitations means that the proposed amendments to the indentures governing the existing notes will not be adopted, potentially limiting the company's debt management strategies and future financing capabilities.
- Merger Unaffected: Despite the termination of the exchange offers and consent solicitations, the proposed acquisition by a consortium led by William McMorrow is expected to close in Q2 2026, indicating the independence of the merger from these financial maneuvers and the continuity of the company's strategic direction.
- Role of Information Agent: D.F. King & Co., Inc. served as the exchange and information agent for the terminated offers, providing necessary support to ensure investors receive timely information, thereby maintaining communication channels between the company and its investors.
See More
